Aileron Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Aileron Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2016 to Q3 2024.
  • Aileron Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 100M shares, a 122% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 100M +55M +122% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 100M +55M +122% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 100M +55M +122% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 45M 0 0% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 45M -255M -85% Sep 30, 2023 10-Q 2023-10-13
Q2 2023 45M -255M -85% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 45M -255M -85% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 45M +30M +200% Dec 31, 2022 10-K 2024-04-15
Q3 2022 300M 0 0% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 300M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 300M +150M +100% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 15M +7.5M +100% Dec 31, 2021 10-K 2023-03-20
Q3 2021 300M +150M +100% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 300M +150M +100% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 150M 0 0% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 7.5M -143M -95% Dec 31, 2020 10-Q 2023-10-13
Q3 2020 150M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 150M 0 0% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 150M 0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 150M 0 0% Dec 31, 2019 10-K 2021-03-24
Q3 2019 150M 0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 150M 0 0% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 150M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 150M 0 0% Dec 31, 2018 10-K 2020-03-30
Q3 2018 150M 0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 150M +6.5M +4.53% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 150M Mar 31, 2018 10-Q 2018-05-09
Q4 2017 150M +6.5M +4.53% Dec 31, 2017 10-K 2019-03-29
Q3 2017 150M Sep 30, 2017 10-Q 2017-11-09
Q2 2017 144M Jun 30, 2017 10-Q 2017-08-10
Q4 2016 144M Dec 31, 2016 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.